Assessment of genetically modified maize DP202216 for food and feed uses, under regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2019-163) by Pioneer

TESTBIOTECH Background 22 – 04 – 2024

Summary:

The GMO Panel assessed maize DP202216 (EFSA, 2024). The maize

  • overexpresses the ZMM28 protein, an endogenous transcription factor in maize,
  • and produces the phosphinothricin acetyl transferase (PAT) protein for tolerance to glufosinate-ammonium-containing herbicides;

Consequently, the maize is resistant to glufosinate herbicides and is supposed to have an increased yield potential.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.